Talzenna Plus Xtandi Shows Significant Overall Survival …
Oct 10, 2024 · The combination of Talzenna (talazoparib; Pfizer) plus Xtandi (enzalutamide; Astellas and Pfizer) produced a statistically significant improvement in overall survival (OS) in …
The Strategic Emergence of Site Networks in Clinical Research
Oct 14, 2024 · These attributes can help sponsors assess the potential of a site or network to meet the specific needs of their trials. For example, a site with a robust infrastructure and …
Teva Shares Positive Phase III Data of Schizophrenia Injectable TEV …
Nov 4, 2024 · Teva has shared results from the Phase III SOLARIS (NCT05693935) clinical trial of TEV-'749 in adult patients diagnosed with schizophrenia. The subcutaneous long-acting …
FDA Finalizes Decentralized Clinical Trial Guidance
Nov 25, 2024 · The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented …
Phase III Trials Show Long-Term Efficacy of Cobenfy Treating …
Nov 1, 2024 · Data from a pair of Phase III trials presented at the 2024 Psych Congress demonstrate that Cobenfy (xanomeline and trospium chloride) maintained long-term efficacy in …
The Roles of Central and Local Labs in Clinical Trials
Nov 11, 2024 · In a recent interview with Applied Clinical Trials, Kelli Aufderheide, director, laboratory decentralized trial solutions, IQVIA Laboratories, discussed the benefits of central …
Omvoh Achieves Long-Term Remission, Symptom Improvement …
Oct 28, 2024 · A pair of multiyear Phase III trials show that Eli Lilly's Omvoh (mirikizumab) produced stable, long-term remission and improved symptoms in patients with ulcerative colitis …
The CRA of the Future: From ‘Road Warrior’ to Site ‘Owner’
Feb 13, 2024 · The role of the clinical research associate (CRA) is fundamentally important to the success of clinical trials. However, this role is undergoing significant transformation due to the …
Ten-Year Data from CheckMate -067 Trial Shows Long-Term …
Sep 16, 2024 · Final efficacy and safety data from the Phase III CheckMate -067 trial (NCT01844505) demonstrated durable survival improvements over 10 years with the …
Four-Steps to Accelerate Study Start-up Cycles - Applied Clinical …
Mar 5, 2024 · Completing study start-up in clinical trials takes determination, coordination, and continuous process improvement. The average time from site identification to study start-up …